Latest Breaking News On - ஜான்சன் இந்தியா - Page 1 : comparemela.com

J&J vaccine: Johnson & Johnson seeks nod for trial of single-dose vaccine on adolescents in India

J&J had earlier applied to the drug regulator seeking emergency use authorisation (EUA) for Covid-19 vaccines for adults.

India central drugs standard control organisationCentral drugs standard control organisationJohnson indiaEmergency use authorisationDrug controller generalJ ampj vaccineJohnson ampJ ampஇந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்ஜான்சன் இந்தியாமருந்து கட்டுப்படுத்தி ஜநரல்ஜான்சன் ஆம்ப்ஜு ஆம்ப்

Johnson & Johnson seeks regulator nod for vax trials in 12-17 age group in India

The American-based pharma major Johnson & Johnson (J&J) has applied to the Central Drugs Standard Control Organisation (CDSCO) for permission to conduct a vaccine trial of the Covid-19 single shot Janssen vaccine in India on children of .

United statesNew delhiMansukh mandaviyaSerum institute covishieldUnion healthCentral drugs standard control organisationEmergency use authorisationDrug controller generalJohnson indiaUnion health minister mansukh mandaviyaEmergency useNow indiaSerum instituteBharat biotechஒன்றுபட்டது மாநிலங்களில்புதியது டெல்ஹி

Johnson & Johnson seeks nod for trial of single-dose vaccine on adolescents in India

Johnson & Johnson has moved an application in India seeking to conduct clinical trials of its single shot Covid vaccine on adolescents aged 12-17 years.

Serum institute covishieldCentral drugs standard control organisationEmergency use authorisationDrugs controller generalJohnson indiaEmergency use authorizationSerum instituteBharat biotechJohnson andOhnson and johnson vaccineOhnson and johnson trials in indiaமைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்மருந்துகள் கட்டுப்படுத்தி ஜநரல்ஜான்சன் இந்தியாஅவசரம் பயன்பாடு அங்கீகாரம்சீரம் நிறுவனம்

Johnson & Johnson sought approval for a trial on children aged 12 to 17 in India | જોનસન એન્ડ જોનસને ભારતમાં 12થી 17 વર્ષનાં બાળકો પર ટ્રાયલ માટે મંજૂરી માગી

Johnson & Johnson sought approval for a trial on children aged 12 to 17 in India | જોનસન એન્ડ જોનસને ભારતમાં 12થી 17 વર્ષનાં બાળકો પર ટ્રાયલ માટે મંજૂરી માગી
divyabhaskar.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from divyabhaskar.co.in Daily Mail and Mail on Sunday newspapers.

Johnson indiaAmerican pharmaCentral drugsDrugs generalஜான்சன் இந்தியாஅமெரிக்கன் பார்மாமைய மருந்துகள்

Johnson & Johnson seeks regulator nod for single-dose Covid vaccine trials on 12-17 age group in India

COVID-19,Coronavirus,COVID-19 vaccine,Johnson Johnson, Johnson and Johnson, Johnson and Johnson vaccine, india, Johnson and Johnson trials in india,coronavirus,India,health,vaccine,coronavirus vaccine,COVID-19 vaccine,Johnson & Johnson,Janssen,SII,Covishield,Bharat Biotech,Covaxin,Sputnik V,Moderna

United statesMansukh mandaviyaSerum institute covishieldUnion healthCentral drugs standard control organisationImage sourceEmergency use authorisationDrug controller generalJohnson indiaUnion health minister mansukh mandaviyaEmergency useNow indiaSerum instituteBharat biotechCovid 19Covid 19 vaccine